<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="116053">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01971268</url>
  </required_header>
  <id_info>
    <org_study_id>II-02</org_study_id>
    <nct_id>NCT01971268</nct_id>
  </id_info>
  <brief_title>Compare the Success Rate of T3 Dental Implant (Biomet 3I) With or Without Platform-switch Concept</brief_title>
  <official_title>Marginal Bone Behavior of Dental Implants to Different Rehabilitation Protocols</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Implantologia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto de Implantologia</source>
  <oversight_info>
    <authority>Portugal: Ethics Committee for Clinical Research</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In patients that received a T3 (Biomet 3I) dental implant, does the use of platform-switch
      concept compared to the use of platform-matched concept, refrain marginal bone loss during
      osseointegration phase (t=12 weeks =T1) and from then to final rehabilitation (t= placement
      of the final restoration = at 18 weeks=T2)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients from a private practice who received dental implants (T3 dental implant Biomet 3I)
      from November 2012 to October 2013 were eligible to enter the study.

      Two groups were formed: one group received a T3 dental implant with platform switch concept
      and the other received an implant with platform matched type of connection.

      We evaluate osseointegration at T1 (12 weeks) and marginal bone position in relation to the
      implant platform at baseline (implant installation) T0 and again at T1 and T2.

      From data recorder in T0,T1 and T2, we evaluate changes in marginal bone position.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>Position of Implant Platform to marginal bone</measure>
    <time_frame>At Baseline (T0)</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Compare marginal bone position at baseline T0 (measured radiographically (digital) from the most coronal position of marginal bone to the most coronal position of the platform, measured in the most mesial and distal part (two measures) of the implant platform.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Marginal Bone Position at 8 Weeks</measure>
    <time_frame>At 12 weeks (T1) after Baseline</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Compare marginal bone position at T1, 12 weeks after baseline (T0) (measured radiographically (digital) from the most coronal position of marginal bone to the most coronal position of the platform, measured in the most mesial and distal part (two measures) of the implant platform</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Marginal Bone Position at 12 Weeks</measure>
    <time_frame>At 18 Weeks (T2) after baseline (T0)</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Compare marginal bone position at T2, 18 weeks from baseline (T0) (measured radiographically (digital) from the most coronal position of marginal bone to the most coronal position of the platform, measured in the most mesial and distal part (two measures) of the implant platform.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Osseointegration</measure>
    <time_frame>At 12 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>measure the ability of the implant to integrate in bone</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Implants</condition>
  <condition>Bone Loss</condition>
  <arm_group>
    <arm_group_label>Platform-Switch Group</arm_group_label>
    <description>T3 dental implant, with platform-switch  dental implant platform concept, measure marginal bone loss</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Platform-Matched Group</arm_group_label>
    <description>T3 dental implant, platform-matched dental implant platform concept, measure marginal bone loss</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dental Implant</intervention_name>
    <description>place dental implants according to manufacturer guidelines</description>
    <arm_group_label>Platform-Switch Group</arm_group_label>
    <arm_group_label>Platform-Matched Group</arm_group_label>
    <other_name>Biomet 3i T3 dental implant</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Platform-Switch Dental Implant</intervention_name>
    <description>Place Dental Implant with an abutment narrower than the implant platform</description>
    <arm_group_label>Platform-Switch Group</arm_group_label>
    <other_name>Biomet 3I Dental Implant Platform-Switch</other_name>
    <other_name>Discrepant Platform implant</other_name>
    <other_name>non-matched dental implant</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Platform-Matched dental implant</intervention_name>
    <description>Place Dental Implant with abutment with same size as the platform</description>
    <arm_group_label>Platform-Matched Group</arm_group_label>
    <other_name>Biomet 3I T3 Dental Implant</other_name>
    <other_name>non-discrepant platform dental implant</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Population from a private office who seek care to replace missing teeth, must have
        economical status to do implant supported rehabilitations
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Single unit implant rehabilitation

          -  Maxilla and mandible

          -  Biomet 3I T3 dental implant placed

          -  Final Rehabilitation placed

        Exclusion Criteria:

          -  Immediate implants

          -  Radiographic impossibility of measure

          -  Absence of baseline T0 radiograph

          -  Smoking habits (more 10 cigarets a day)

          -  Diabetes

          -  Patients who receive Radio or/and Chemotherapy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andre Chen, Msc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto de Implantologia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>João Caramês, Phd</last_name>
    <role>Study Director</role>
    <affiliation>Instituto de Implantologia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Helena Francisco, Msc</last_name>
    <role>Study Chair</role>
    <affiliation>Instituto de Implantologia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elena Cervino, Msc</last_name>
    <role>Study Chair</role>
    <affiliation>Instituto de Implantologia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>André Chen, Msc</last_name>
    <phone>00351919774343</phone>
    <email>tsouchen@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elena Cervino, Msc</last_name>
    <phone>00351919074338</phone>
    <email>elecer@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Instituto de Implantologia</name>
      <address>
        <city>Lisbon</city>
        <zip>1500-662</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joana Velez</last_name>
      <email>joana.velez@institutodeimplantologia.com</email>
    </contact>
    <investigator>
      <last_name>Andre Chen, Msc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>João Caramês, Msc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Helena Francisco, Msc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elena Cervino, Msc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 23, 2013</lastchanged_date>
  <firstreceived_date>October 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto de Implantologia</investigator_affiliation>
    <investigator_full_name>Andre Chen</investigator_full_name>
    <investigator_title>Mcs</investigator_title>
  </responsible_party>
  <keyword>T3 dental implants</keyword>
  <keyword>Marginal bone loss</keyword>
  <keyword>Survival rate</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cimetidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
